The broader issue here is the erosion of regulatory standards that exist to protect patients
Simm PJ, Bicknell-Royle J, Lawrie J, Nation J, Draffin K, Stewart KG, et al
For general scalp health and skin benefits that may indirectly support hair, GHK-CU remains valuable
Colhoun, MD, the AXA Chair in Medical Informatics and Life Course Epidemiology at the University of Edinburgh in Scotland, United Kingdom, and lead author of this study, in a press release
The Truth About Severe Adverse Reactions As far as presently available scientific literature goes, there is indication of a high safety profile for NAD IV therapy, with no large-scale or well-documented reports of severe or life-threatening reactions to the treatment